The Dividend Note
Dividend notes: in a sweet spot - CCH, ROR, HILS (18/08/23)
I review recent half-year results from Coca-Cola HBC, valve actuator specialist Rotork and infrastructure group Hill & Smith.
The Dividend Note
I review recent half-year results from Coca-Cola HBC, valve actuator specialist Rotork and infrastructure group Hill & Smith.
The Dividend Note
I give my view on recent results and acquisition news from BAE Systems, Admiral and Aviva.
Podcasts
Maynard Paton, Bruce Packard, Mark Simpson and myself enjoy a lively four-way debate about shares and discuss our approach to asset allocation.
The Dividend Note
I review recent results from Savills (profit warning), Persimmon, Derwent London and property lender Real Estate Credit Investments.
The Dividend Note
I consider the appeal (or not) of cyclical dividends from BP, Taylor Wimpey, Tritax Big Box REIT and Robert Walters.
Portfolio
My dividend portfolio companies produced a bumper crop of updates in July. I don't see any new problems and remain confident about the medium-term outlook, despite some niggling concerns.
The Dividend Note
I find potential signs of value among half-year results from British American Tobacco, AstraZeneca and Spirent Communications.
The Dividend Note
I review the latest updates from Shell, B&M European Value Retail and RS Group and follow up concerns I've previously flagged up.
The Dividend Note
I review half-year results from Lloyds and GSK and consider today's more downbeat commentary from IT group FDM.
The Dividend Note
I look at the latest results from Croda International, Howden Joinery and AJ Bell. These businesses all have a track record of super profitability but are facing weaker market conditions. I'm hunting for potential buying opportunities.
Dividend share reviews
Shell (LON:SHEL) is one of the most popular FTSE 100 dividend shares. How does this energy giant score in my screening system?
The Dividend Note
My founder theme continues with a look at a potentially revealing update from Hargreaves Lansdown and solid results from defence small-cap Cohort.
Disclaimer: All content provided on this website is intended for educational and entertainment purposes only. This website does not provide investment advice or recommendations. You should research all investment decisions yourself and not rely upon information provided on this website. If you are unable to do this you should seek professional advice from a registered financial adviser.